Medtronic plc MDT

Full chart Compare
Set alert

Price alert · MDT

All alert types
104.84 USD -0.12 (-0.11%)

At closeNov 5, 2026, 6:58 PM EST

104.25 -0.59 -0.56%

After hours · Nov 5, 6:58 PM ET

103.31 Day range 106.20
73.31 52-week range 106.33
YTD
+9.14%
1 year
+15.97%
Market cap
134.10B
Revenue (ttm)
37.54B
Profit margin
13.93%
EPS (ttm)
4.07
Shares out
1.28B
P/E ratio
25.76
Forward P/E
16.40
Dividend
2.88 (2.91%)
Ex-dividend date
Sep 24, 2026
YTD return
+9.14%
1-year return
+15.97%
Volume
11.60M
Avg volume
16.56M
Open
106.05
Previous close
104.96
Day's range
103.31 – 106.20
52-week range
73.31 – 106.33
Beta
0.57
Analysts
Buy
Price target
104.62 (-0.2%)
Earnings date
Nov 17, 2026

5D +7.22 (+7.40%)

100105FriMonTueWedThu104.83

Key statistics

Enterprise value
146.43B
PEG ratio
1.78
Price / sales
3.58
Price / book
2.68
Dividend yield
2.91%
Payout ratio
70.02%
Revenue growth
13.70%
Free cash flow
5.41B
Total cash
8.82B
Total debt
28.15B
Return on equity
10.65%
Short % of float
10.89%
50-day average
91.94
200-day average
88.17

Financials — quick view

All financials
MDT Revenue — quarterly 9.76B
2023-Q2 20222023-Q3 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20262027-Q1 2026
MDT Net income — quarterly 1.47B
2023-Q2 20222023-Q3 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20262027-Q1 2026
MDT EPS — quarterly 1.15
2023-Q2 20222023-Q3 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20262027-Q1 2026

Earnings

MDT recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 17, 2026Oct 31, 20261.33———
Sep 1, 2026Jul 31, 20261.391.45+0.06+4.32%
Jun 3, 2026Apr 24, 20261.541.55+0.01+0.65%
Feb 17, 2026Jan 23, 20261.341.36+0.02+1.49%
Nov 18, 2025Oct 24, 20251.311.36+0.05+3.82%
Aug 19, 2025Jul 25, 20251.231.26+0.03+2.44%

Upgrades / downgrades

MDT analyst upgrades and downgrades
DateFirmActionFromTo
Oct 12, 2026BTIGmainBuyBuy
Oct 7, 2026Barclaysinit—Equal-Weight
Sep 30, 2026TD CowenreitBuyBuy
Sep 3, 2026UBSmainBuyBuy
Sep 2, 2026Truist SecuritiesreitHoldHold
Sep 2, 2026Wells FargomainOverweightOverweight

About Medtronic plc

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

Sector
Healthcare
Industry
Medical Devices
Country
Ireland

News

Your note

Sign in to keep a note on MDT — it syncs with the Stock Master app.

Institution ownership

MDT institution ownership
Holder% heldSharesValueReported
Blackrock Inc.8.91%114,020,78711.98BJun 29, 2026
Vanguard Capital Management LLC6.55%83,816,7358.80BJun 29, 2026
State Street Corporation4.96%63,399,3156.66BJun 29, 2026
Vanguard Portfolio Management LLC2.66%34,059,9673.58BJun 29, 2026
Geode Capital Management, LLC2.36%30,192,0153.17BJun 29, 2026
JPMORGAN CHASE & CO2.17%27,784,4712.92BJun 29, 2026

Fund ownership

MDT fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.19%40,757,4224.28BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.60%33,271,4573.49BJun 29, 2026
iShares Trust-iShares Core S&P 500 ETF1.33%17,056,2981.79BSep 29, 2026
Fidelity Concord Street Trust-Fidelity 500 Index Fund1.30%16,635,4181.75BSep 29, 2026
SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust1.24%15,820,5821.66BSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Value Index Fund0.96%12,221,6431.28BJun 29, 2026